Oligotherapy was introduced as treatment thanks to the works of a French physician, J. Ménétrier. During the 1930s, J. Ménétrier carried out the empirical experimentation and the clinical trial on oligoelements starting from G. Bertrand’s preliminary works. The doses of oligoelements used in catalytic oligotherapy are, in most cases, very close to the physiological requirements of these fundamental oligoelements.
The oligoelements used in these catalytic doses can remove the metabolic blocks that clinically result in functional disorders that can develop into organic lesions.
Functional medicine recalls the concept of “ground” for the individual and requires a global and customized approach to the patient.